St. Vincent & Grenadines Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Health Press.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on April 10, 2026

Apr. 10, 2026

Gentle Patches Claims Evaluated: 2026 Consumer Interest Rises Around Transdermal Wellness Patch Ingredients, Product Lineup, and Policy Transparency

GlobeNewswire

Apr. 10, 2026

Glo & Spa-rkle Aesthetics and Medical Spa Unveils New State-of-the-Art Location in Lubbock, Texas

GlobeNewswire

Apr. 10, 2026

IVY Rx Claims Evaluated: 2026 Compounded GLP-1 Telehealth Program Details, Monthly Pricing Structure, Clinician Access Model, and Patient Eligibility Information

GlobeNewswire

Apr. 10, 2026

ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility

GlobeNewswire

Apr. 10, 2026

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

GlobeNewswire

Apr. 10, 2026

Pelthos Therapeutics Announces CFO Transition

GlobeNewswire

Apr. 10, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Apr. 10, 2026

Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION

GlobeNewswire

Apr. 10, 2026

Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026

GlobeNewswire

Apr. 10, 2026

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Apr. 10, 2026

Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026

GlobeNewswire

Apr. 10, 2026

IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

GlobeNewswire

Apr. 10, 2026

Best Medical Alert Systems 2026: Bay Alarm Medical Awarded Best Medical Alert System

GlobeNewswire

Apr. 10, 2026

Suja Life Announces Filing of Registration Statement for Proposed Initial Public Offering

GlobeNewswire

Apr. 10, 2026

Matricis.ai Launches First U.S. Clinical Pilot of EndomAI for AI-Assisted Detection of Endometriosis with SimonMed

GlobeNewswire

Apr. 10, 2026

Novarad to Showcase Surgical Augmented Reality Platform VisAR at SIR 2026

GlobeNewswire

Apr. 10, 2026

The Ebony Canal Announces Global Birth Equity Tour Following Award-Winning Season

GlobeNewswire

Apr. 10, 2026

Humber River Health Renames Wilson Site Hennick Humber Hospital Following Transformational $50 Million Gift

GlobeNewswire

Apr. 10, 2026

Get Medicaid Facts: New Site and Toolkit Launched to Educate Public About Looming Medicaid Eligibility Changes

GlobeNewswire

Apr. 10, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Strengthening Position with AI-Driven Tech in Automated Compliance Space

GlobeNewswire